Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location

Figure 1

Fluoroquinolone resistance. The following fluoroquinolone abbreviations were used in this and subsequent figures: CIP, ciprofloxacin; GAT, gatifloxacin; LVX, levofloxacin; NOR, norfloxacin; and OFX, ofloxacin. For these and subsequent graphs, the number of isolates in each category is shown above each bar. The frequency of resistance increased significantly by Chi-square tests (P ≤ 0.01) each year except from 1999 to 2000 and 2001 to 2002. (A) Average percentage of non-susceptible isolates from 1999 to 2004 for each fluoroquinolone. Resistant ("R") and intermediate ("I") isolates for each fluoroquinolone are shown. With regards to statistical significance, levofloxacin and ofloxacin resistance was the same by Chi-square analysis, and both were distinct from ciprofloxacin, gatifloxacin, and norfloxacin. (B) Total fluoroquinolone non-susceptibility over time. The average percentage of "R" and "I" isolates for all the tested fluoroquinolones combined for each year is shown. (C) Percentage of non-susceptible isolates for each fluoroquinolone in 2002.

Back to article page